BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 9452328)

  • 1. Abnormalities in the stride length-cadence relation in parkinsonian gait.
    Morris M; Iansek R; Matyas T; Summers J
    Mov Disord; 1998 Jan; 13(1):61-9. PubMed ID: 9452328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of gait hypokinesia in Parkinson's disease.
    Morris ME; Iansek R; Matyas TA; Summers JJ
    Brain; 1994 Oct; 117 ( Pt 5)():1169-81. PubMed ID: 7953597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Automatic motion analysis of gait in patients with Parkinson disease: effects of levodopa and visual stimulations].
    Azulay JP; Van Den Brand C; Mestre D; Blin O; Sangla I; Pouget J; Serratrice G
    Rev Neurol (Paris); 1996 Feb; 152(2):128-34. PubMed ID: 8761620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual task interference during gait in people with Parkinson disease: effects of motor versus cognitive secondary tasks.
    O'Shea S; Morris ME; Iansek R
    Phys Ther; 2002 Sep; 82(9):888-97. PubMed ID: 12201803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhythmic auditory stimulation modulates gait variability in Parkinson's disease.
    Hausdorff JM; Lowenthal J; Herman T; Gruendlinger L; Peretz C; Giladi N
    Eur J Neurosci; 2007 Oct; 26(8):2369-75. PubMed ID: 17953624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
    Kwon KY; Lee HM; Kang SH; Pyo SJ; Kim HJ; Koh SB
    Gait Posture; 2017 Oct; 58():1-6. PubMed ID: 28692855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
    O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
    Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.
    Morris M; Iansek R; McGinley J; Matyas T; Huxham F
    Mov Disord; 2005 Jan; 20(1):40-50. PubMed ID: 15390033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gait disorders in Parkinson's disease: and pathophysiological approaches].
    Moreau C; Cantiniaux S; Delval A; Defebvre L; Azulay JP
    Rev Neurol (Paris); 2010 Feb; 166(2):158-67. PubMed ID: 19616816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validity of the GaitRite and the Functional Ambulation Performance scoring system in the analysis of Parkinson gait.
    Nelson AJ; Zwick D; Brody S; Doran C; Pulver L; Rooz G; Sadownick M; Nelson R; Rothman J
    NeuroRehabilitation; 2002; 17(3):255-62. PubMed ID: 12237507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of visual and auditory cues on gait in individuals with Parkinson's disease.
    Suteerawattananon M; Morris GS; Etnyre BR; Jankovic J; Protas EJ
    J Neurol Sci; 2004 Apr; 219(1-2):63-9. PubMed ID: 15050439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic modulation of timing control and variability in the gait of Parkinson's disease.
    Almeida QJ; Frank JS; Roy EA; Patla AE; Jog MS
    Mov Disord; 2007 Sep; 22(12):1735-42. PubMed ID: 17557356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral coordination of walking and freezing of gait in Parkinson's disease.
    Plotnik M; Giladi N; Hausdorff JM
    Eur J Neurosci; 2008 Apr; 27(8):1999-2006. PubMed ID: 18412621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gait analysis in patients with Parkinson's disease off dopaminergic therapy.
    Svehlík M; Zwick EB; Steinwender G; Linhart WE; Schwingenschuh P; Katschnig P; Ott E; Enzinger C
    Arch Phys Med Rehabil; 2009 Nov; 90(11):1880-6. PubMed ID: 19887212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of subthalamic nucleus stimulation and L-dopa in trunk kinematics of patients with Parkinson's disease.
    Ferrarin M; Rizzone M; Lopiano L; Recalcati M; Pedotti A
    Gait Posture; 2004 Apr; 19(2):164-71. PubMed ID: 15013505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease.
    Faist M; Xie J; Kurz D; Berger W; Maurer C; Pollak P; Lücking CH
    Brain; 2001 Aug; 124(Pt 8):1590-600. PubMed ID: 11459750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual kinesthesia and locomotion in Parkinson's disease.
    Schubert M; Prokop T; Brocke F; Berger W
    Mov Disord; 2005 Feb; 20(2):141-50. PubMed ID: 15390031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locomotor response to levodopa in fluctuating Parkinson's disease.
    Moore ST; MacDougall HG; Gracies JM; Ondo WG
    Exp Brain Res; 2008 Feb; 184(4):469-78. PubMed ID: 17828529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity.
    Chastan N; Do MC; Bonneville F; Torny F; Bloch F; Westby GW; Dormont D; Agid Y; Welter ML
    Mov Disord; 2009 Jan; 24(2):188-95. PubMed ID: 18973252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Walking along circular trajectories in Parkinson's disease.
    Guglielmetti S; Nardone A; De Nunzio AM; Godi M; Schieppati M
    Mov Disord; 2009 Mar; 24(4):598-604. PubMed ID: 19117359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.